x
Breaking News
More () »

Buffalo-based biotech startup inks deal with Chinese pharma giant worth up to $148 million

The company – which is developing an anti-cancer immunotherapy for the treatment of glioblastoma brain tumors – has reached a deal with a Shanghai company.
Buffalo skyline (Photo: WGRZ)

BUFFALO, N.Y. — MimiVax has long presented an exciting opportunity to develop a cutting-edge cancer therapy in Buffalo.

Now the spinout from Roswell Park Comprehensive Cancer Center is a lot closer to that goal. For more on this story, please visit the Buffalo Business First website.

Before You Leave, Check This Out